These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 6086217)
1. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci. Jones RN; Barry AL; Packer RR Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):37S-46S. PubMed ID: 6086217 [TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activity of cefoxitin, cefotaxime alone, and in combination with desacetylcefotaxime against the Bacteroides species. Canawati HN Diagn Microbiol Infect Dis; 1989; 12(1):33-7. PubMed ID: 2714070 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of cefotaxime alone and in combination with desacetylcefotaxime against Bacteroides fragilis. Wasilauskas BL Diagn Microbiol Infect Dis; 1989; 12(1):39-43. PubMed ID: 2714071 [TBL] [Abstract][Full Text] [Related]
4. In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides. Aldridge KE; Sanders CV; Marier RL Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):47S-53S. PubMed ID: 6086218 [TBL] [Abstract][Full Text] [Related]
5. A reassessment of the activity of the third-generation cephalosporins against anaerobes and Staphylococcus aureus. Canawati HN Am J Surg; 1992 Oct; 164(4A Suppl):24S-27S. PubMed ID: 1443357 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes. Werner H; Heizmann W; Luft G Arzneimittelforschung; 1988 Nov; 38(11):1553-6. PubMed ID: 3214438 [TBL] [Abstract][Full Text] [Related]
7. Comparison of agar dilution, microdilution, and disk elution methods for measuring the synergy of cefotaxime and its metabolite against anaerobes. Smith JA; Henry D; Ngui-Yen J; Castell A; Coderre S J Clin Microbiol; 1986 Jun; 23(6):1104-8. PubMed ID: 2872231 [TBL] [Abstract][Full Text] [Related]
8. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism. Chin NX; Neu HC Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):21S-31S. PubMed ID: 6086215 [TBL] [Abstract][Full Text] [Related]
9. A comparison of susceptibility results of the Bacteroides fragilis group and other anaerobes by traditional MIC results and statistical methods. Aldridge KE; Johnson WD J Antimicrob Chemother; 1997 Mar; 39(3):319-24. PubMed ID: 9096180 [TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group. Bourgault AM; Lamothe F J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the in vitro action and interaction of cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides spp. Aldridge KE Diagn Microbiol Infect Dis; 1989; 12(1):45-50. PubMed ID: 2714072 [TBL] [Abstract][Full Text] [Related]
12. Interaction of cefotaxime and desacetylcefotaxime against pathogenic bacteria. Assessment with the serum bactericidal test. Reller LB Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):55S-61S. PubMed ID: 6086219 [TBL] [Abstract][Full Text] [Related]
13. The synergistic effect of cefotaxime and desacetylcefotaxime against clinical isolates of anaerobic bacteria. Devlin HR; Boskovski L Drugs; 1988; 35 Suppl 2():45-50. PubMed ID: 3396488 [TBL] [Abstract][Full Text] [Related]
14. The activity of cefotaxime and desacetylcefotaxime against Bacteroides species compared to 7-methoxy cephems and other anti-anaerobe drugs. Jones RN J Antimicrob Chemother; 1984 Sep; 14 Suppl B():39-43. PubMed ID: 6094461 [TBL] [Abstract][Full Text] [Related]
15. An in vitro study of the interaction between cefotaxime and desacetylcefotaxime. Winstanley TG; Spencer RC Drugs Exp Clin Res; 1986; 12(12):967-71. PubMed ID: 3471432 [TBL] [Abstract][Full Text] [Related]
16. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin. Pankuch GA; Jacobs MR; Appelbaum PC Antimicrob Agents Chemother; 1993 Aug; 37(8):1649-54. PubMed ID: 8215278 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the bactericidal activity of cefotaxime and desacetylcefotaxime alone and in combination against Bacteroides fragilis group organisms. Aldridge KE; Weeks LS; Stratton CW; Sanders CV Diagn Microbiol Infect Dis; 1989; 12(2):165-70. PubMed ID: 2752714 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group. Stratton CW; Weeks LS; Aldridge KE Diagn Microbiol Infect Dis; 1992; 15(4):321-30. PubMed ID: 1611847 [TBL] [Abstract][Full Text] [Related]
19. The activity of ticarcillin in combination with clavulanic acid against Bacteroides species: an in-vitro comparison with other antibiotics. de Barbeyrac B; Quentin C; Bébéar C J Antimicrob Chemother; 1986 May; 17 Suppl C():35-9. PubMed ID: 3636337 [TBL] [Abstract][Full Text] [Related]
20. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan. Teng LJ; Hsueh PR; Tsai JC; Liaw SJ; Ho SW; Luh KT Antimicrob Agents Chemother; 2002 Sep; 46(9):2908-13. PubMed ID: 12183246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]